THRD — Third Harmonic Bio Share News
0.000.00%
- $242.79m
- -$28.82m
Third Harmonic Bio Inc expected to post a loss of 31 cents a share - Earnings Preview
Brief: Third Harmonic Bio Announces Plan Of Liquidation And Dissolution
Third Harmonic Bio Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Third Harmonic Bio Q4 Net Income USD -13.1 Million
Third Harmonic Bio Inc expected to post a loss of 34 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-AN2 Therapeutics, Ecolab, RPM International
Brief: Third Harmonic Bio Q1 Net Income USD 7.856 Million
Brief: Third Harmonic Bio Appoints Geoff McDonough To Board
U.S. RESEARCH ROUNDUP-Acuity Brands, CSG Systems International, Nuvation Bio
Brief: Third Harmonic Bio Appoints Christopher Murphy As Chief Financial And Business Officer
Brief: Third Harmonic Bio Q3 net income USD -7.3 million
Brief: Third Harmonic Bio Announces Leadership Changes
Brief: Third Harmonic Bio Got Notice From Robert Ho Of His Intention To Resign As Company's Chief Financial Officer, Effective November 10
Brief: Third Harmonic Bio Inc Files For Mixed Shelf Of Up To $400 Million – SEC Filing
Brief: Third Harmonic Bio Announces Next-Generation Oral Kit Inhibitor Product Candidate
Brief: Third Harmonic Bio Announces First Quarter 2023 Financial Results
Brief: Third Harmonic Bio Reports Q4 Net Loss Of $11.5 Mln
U.S. RESEARCH ROUNDUP- Adobe, Costar, Verisign
U.S. STOCKS ON THE MOVE-Trip.com, Verizon Communications, Netflix